← Back to Search

Behavioural Intervention

Expressive Writing for Emotional Well-Being

N/A
Recruiting
Led By Erik Nook, PhD
Research Sponsored by Trustees of Princeton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial visit (day 1), final visit (day 15), 1-month follow-up (1 month after day 14)

Summary

This trial looks at how expressive writing impacts young adults differently when they imagine talking to themselves vs. a loved one. 159 people will take part, each in one of 3 groups.

Who is the study for?
This trial is for US-based, English-speaking young adults experiencing mild symptoms of depression or anxiety. Participants must have a certain score on mental health questionnaires to join. They can't take part if they don't write for at least 15 minutes daily or miss three days in a row.
What is being tested?
The study tests the effects of expressive writing when directed towards oneself versus someone close, compared with factual writing about daily routines. Over two weeks, participants will be randomly placed into one of three groups and asked to write each day according to their group's theme.
What are the potential side effects?
Since this trial involves writing exercises, there are no direct physical side effects expected from participation. However, discussing deep thoughts and feelings could potentially cause temporary emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial visit (day 1), final visit (day 15), 1-month follow-up (1 month after day 14)
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial visit (day 1), final visit (day 15), 1-month follow-up (1 month after day 14) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety
Depression
Other study objectives
Alexithymia (PAQ)
Alexithymia (TAS)
Daily Sleep
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: SelfExperimental Treatment1 Intervention
The Self group is instructed to carry out the expressive writing exercise as if they were writing to themselves.
Group II: OtherExperimental Treatment1 Intervention
The Other group is instructed to carry out the expressive writing exercise as if they were writing to someone they feel close to.
Group III: ControlPlacebo Group1 Intervention
The Control group is asked to write down a factual description of their routine that day, as if they were writing to themselves.

Find a Location

Who is running the clinical trial?

Trustees of Princeton UniversityLead Sponsor
1 Previous Clinical Trials
1,500 Total Patients Enrolled
Erik Nook, PhDPrincipal InvestigatorPrinceton University
~79 spots leftby Nov 2025